Original Research Article Background: Acute leukaemia is a clonal malignant disorder affecting all age groups. It is characterized by the accumulation of immature blast cells in the bone marrow. This results in bone marrow failure, reflected by peripheral blood cytopenias and circulating blast cells. In most cases the etiology is not obvious, but internal and external factors associated with damage to DNA can predispose to acute leukaemia. Objective: In this study our main goal is to evaluate the effectiveness of serum magnesium level in patients with newly diagnosed acute leukemia. Method: This Observational cross-sectional study was done at Department of Haematology, BSMMU, Dhaka from September 2016 to August 2017. During the study period of total 85 patients were enrolled for the study. Results: Most of the patient's age was found 36.17(±19.15) years, majority age group was found 10-40 years of age which was (62.4%). Regarding gender 55% were found male and 45% were found female and educational status 45(54.12%) were primary level, 21(24.71%) were SSC, 5(5.88%) were HSC and 07(8.24%). Majority (60%) of the patients were found married. Majority 59% of the patients came from poor class socioeconomic status followed by 40% were came from middle class socioeconomic status. Regarding occupational status 33(38.82%) were house wife, 10(11.76%) were day laborer, 12(14.12%) were farmer and 19(22.35%) was student. Regarding acute leukemia majority 60(70.6%) were found AML and 25(29.4%) ALL. Conclusion: From our result we can conclude that, significantly lower serum magnesium level was found in newly diagnosed acute leukemia patients. Among them significantly lower in ALL patients than AML patients. Half of the acute leukemia patients were found hypomagnesaemia.
During the study period of total 60 patients (30 patients with malignant ascites and 30 patients with nonmalignant ascites) were enrolled for the study. Results: Mean ascetic fluid fibronectin was found 0.50±0.15µg/ml in malignant ascites group and 0.22±0.07µg/ml in nonmalignant ascites group. Mean ascitic fluid fibronectin was found 0.64±0.11 µg/ml in positive for malignant cell group and 0.45±0.17 µg/ml in negative for malignant cell group. The mean difference was not statistically significant (p>0.05) between two groups. Sensitivity of cut off value of ascitic fluid fibronectin ≥0.22 µg/ml was 82.86%, specificity 96.0%, accuracy 88.33%, positive and negative predictive values were 96.67% and 80.0% respectively. Conclusion: The present study revealed on the usefulness of fibronectin in the differential diagnosis of ascites and these data and findings suggest that fibronectin may have potential value to differentiate malignant from nonmalignant ascites.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.